Willem Joost Wiersinga
Overview
Explore the profile of Willem Joost Wiersinga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Chilunga F, Appelman B, van Vugt M, Kalverda K, Smeele P, van Es J, et al.
Lancet Reg Health Eur
. 2023 Jun;
29:100630.
PMID: 37261215
Background: Comprehensive data on long COVID across ethnic and migrant groups are lacking. We investigated incidence, nature of symptoms, clinical predictors, and duration of long COVID among COVID-19 hospitalised patients...
3.
Turgman O, Schinkel M, Wiersinga W
Crit Care
. 2023 Mar;
27(1):97.
PMID: 36941681
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2023. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2023 . Further...
4.
Schuurman A, Leopold V, Pereverzeva L, Chouchane O, Reijnders T, de Brabander J, et al.
Thromb Haemost
. 2022 Jul;
122(10):1683-1692.
PMID: 35850149
Background: Activated platelets have been implicated in the proinflammatory and prothrombotic phenotype of coronavirus disease 2019 (COVID-19). While it is increasingly recognized that lipids have important structural and signaling roles...
5.
Schuurman A, Kullberg R, Wiersinga W
Antibiotics (Basel)
. 2022 Feb;
11(2).
PMID: 35203819
The understanding of the gut microbiome in health and disease has shown tremendous progress in the last decade. Shaped and balanced throughout life, the gut microbiome is intricately related to...
6.
Appelman B, Oppelaar J, Broeders L, Wiersinga W, Peters-Sengers H, Vogt L
Sci Rep
. 2022 Feb;
12(1):2258.
PMID: 35145189
Chronic kidney disease (CKD) has been recognized as a highly prevalent risk factor for both the severity of coronavirus disease 2019 (COVID-19) and COVID-19 associated adverse outcomes. In this multicenter...
7.
van den Berg F, van Dalen D, Hyoju S, van Santvoort H, Besselink M, Wiersinga W, et al.
Gut
. 2020 Sep;
70(5):915-927.
PMID: 32873697
Objective: The gut microbiota are the main source of infections in necrotising pancreatitis. We investigated the effect of disruption of the intestinal microbiota by a Western-type diet on mortality and...
8.
Osuchowski M, Ayala A, Bahrami S, Bauer M, Boros M, Cavaillon J, et al.
Intensive Care Med Exp
. 2018 Aug;
6(1):26.
PMID: 30112605
Background: Pre-clinical animal studies precede the majority of clinical trials. While the clinical definitions of sepsis and recommended treatments are regularly updated, a systematic review of pre-clinical models of sepsis...
9.
Harris V, Haak B, Handley S, Jiang B, Velasquez D, Hykes Jr B, et al.
Cell Host Microbe
. 2018 Aug;
24(2):197-207.e4.
PMID: 30092197
Rotavirus vaccines (RVV) protect against childhood gastroenteritis caused by rotavirus (RV) but have decreased effectiveness in low- and middle-income settings. This proof-of-concept, randomized-controlled, open-label trial tested if microbiome modulation can...
10.
Wolff N, Hugenholtz F, Wiersinga W
Crit Care
. 2018 Mar;
22(1):78.
PMID: 29559006
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2018. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2018 . Further...